Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Localized scleroderma is an autoimmune disorder.

K Takehara1, S Sato

  • 1Department of Dermatology, Kanazawa University Graduate School of Medical Sciences, Kanazawa, Japan. takehara@med.kanazawa-u.ac.jp

Rheumatology (Oxford, England)
|November 25, 2004
PubMed
Summary

Localized scleroderma exhibits significant autoimmune activity, primarily targeting the skin. Autoimmune abnormalities in localized scleroderma differ from systemic sclerosis, with specific autoantibodies like anti-histone being prevalent.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Association of sociodemographic and maternal healthcare factors with birth registration in Angola.

Public health·2023
Same author

Autoantibody to transcriptional intermediary factor-1β as a myositis-specific antibody: clinical correlation with clinically amyopathic dermatomyositis or dermatomyositis with mild myopathy.

The British journal of dermatology·2018
Same author

Four cases of anti-Mi-2 antibody-positive dermatomyositis: relationship between anti-Mi-2 antibody titre and disease severity and activity.

Journal of the European Academy of Dermatology and Venereology : JEADV·2017
Same author

Examining the accuracy of visual diagnosis of tinea pedis and tinea unguium in aged care facilities.

Journal of wound care·2017
Same author

OBP-401-GFP telomerase-dependent adenovirus illuminates and kills high-metastatic more effectively than low-metastatic triple-negative breast cancer in vitro.

Cancer gene therapy·2017
Same author

Specimens processed with an extraction solution of the Dermatophyte Test Strip can be used for direct microscopy.

The British journal of dermatology·2016

Area of Science:

  • Immunology
  • Dermatology
  • Autoimmune Diseases

Background:

  • Localized scleroderma is increasingly recognized for its strong autoimmune underpinnings.
  • Lesions are typically confined to the skin and subcutaneous tissues.
  • A comprehensive review of localized scleroderma's autoimmunity is lacking.

Purpose of the Study:

  • To review and summarize existing data on the autoimmune background of localized scleroderma.
  • To consolidate findings from the past two decades concerning localized scleroderma autoimmunity.

Main Methods:

  • Categorization of previous research into antinuclear antibodies, cytokines/receptors, and cell adhesion/surface molecules.
  • Analysis of key investigations within each category.

Related Experiment Videos

Main Results:

  • High prevalence of antinuclear antibodies, particularly anti-histone antibodies, confirmed across studies.
  • Detection of anti-topoisomerase II alpha antibody in localized scleroderma, contrasting with anti-topoisomerase I antibody (specific to systemic sclerosis).
  • Elevated serum cytokines and cell adhesion molecules indicate immunoactivation in localized scleroderma.

Conclusions:

  • Localized scleroderma involves distinct autoimmune abnormalities, positioning it as an organ-specific autoimmune disorder.
  • The autoimmune profile of localized scleroderma differs from that of systemic sclerosis.
  • Autoimmune processes are central to the pathogenesis of localized scleroderma.